Which of the following drugs is NOT used in the management of CMV retinitis?
Which of the following drugs used in the treatment of AIDS patients can cause bone marrow depression?
What is the drug of choice for antibiotic-associated pseudomembranous colitis?
Which of the following are indications for the use of antibiotics in diarrhea?
What is the best method of treatment for ulnar nerve abscess in case of leprosy?
Redman syndrome is a side effect of which of the following drugs?
Which of the following antimicrobials has antipseudomonal action?
Which of the following statements regarding chloroquine is FALSE?
Ethambutol is avoided in children as it causes which adverse effect?
Which of the following is true regarding Metronidazole in amoebiasis?
Explanation: **Explanation:** The correct answer is **Acyclovir**. **1. Why Acyclovir is the correct answer:** Acyclovir is highly effective against Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV), but it has **minimal activity against Cytomegalovirus (CMV)**. This is because Acyclovir requires initial phosphorylation by a viral-specific enzyme called **Thymidine Kinase** to become active. CMV lacks this specific enzyme (it uses a protein kinase called UL97 instead), making Acyclovir ineffective for treating CMV infections like retinitis. **2. Analysis of incorrect options:** * **Ganciclovir:** This is the **drug of choice** for CMV retinitis. It is phosphorylated by the CMV-specific protein kinase **UL97**, allowing it to inhibit CMV DNA polymerase effectively. * **Foscarnet:** An inorganic pyrophosphate analog that directly inhibits viral DNA polymerase without requiring activation by viral kinases. It is used as a second-line agent or when resistance to Ganciclovir occurs. * **Cidofovir:** A nucleotide analog that is already phosphorylated. It does not require viral enzymes for activation and is used for CMV retinitis, particularly in patients with Ganciclovir resistance. **3. NEET-PG High-Yield Pearls:** * **Valganciclovir:** The oral prodrug of Ganciclovir; it is the preferred agent for induction and maintenance therapy of CMV retinitis due to its high oral bioavailability. * **Major Side Effects:** * **Ganciclovir:** Bone marrow suppression (Neutropenia). * **Foscarnet/Cidofovir:** Nephrotoxicity. * **Cidofovir Administration:** Must be given with **Probenecid** and aggressive hydration to reduce nephrotoxicity. * **Letermovir:** A newer drug that inhibits the CMV DNA terminase complex, used for prophylaxis in transplant recipients.
Explanation: **Explanation:** The correct answer is **Cotrimoxazole**. **1. Why Cotrimoxazole is correct:** Cotrimoxazole is a combination of Sulfamethoxazole and Trimethoprim. It is frequently used in AIDS patients for the prophylaxis and treatment of *Pneumocystis jirovecii* pneumonia (PCP) and Toxoplasmosis. The drug works by inhibiting sequential steps in bacterial folic acid synthesis. However, in high doses or prolonged use—common in immunocompromised patients—it can interfere with human folate metabolism, leading to **megaloblastic anemia, leukopenia, and thrombocytopenia** (bone marrow depression). **2. Why the other options are incorrect:** * **Zidovudine (AZT):** While Zidovudine is a notorious cause of bone marrow suppression (specifically macrocytic anemia and neutropenia), it is an **Antiretroviral (ARV)** drug. In the context of this specific question's framing or if compared against Cotrimoxazole in certain clinical scenarios involving opportunistic infection management, Cotrimoxazole remains a high-yield answer for marrow toxicity. *Note: If this were a "Multiple Correct" style, Zidovudine would also be correct, but in single-best-answer formats, Cotrimoxazole is often highlighted for its toxicity in the AIDS population.* * **Didanosine (ddI):** The dose-limiting toxicity of Didanosine is **acute pancreatitis** and peripheral neuropathy, not bone marrow depression. * **Zalcitabine (ddC):** The primary side effect is **peripheral neuropathy** and oral ulcers. **3. High-Yield Clinical Pearls for NEET-PG:** * **Zidovudine (AZT):** Most common side effect is anemia; it is also used for preventing vertical transmission (mother-to-child). * **Didanosine:** Mnemonic "P" – Pancreatitis, Peripheral neuropathy. * **Abacavir:** Associated with life-threatening **Hypersensitivity reactions** (linked to HLA-B*5701). * **Nevirapine:** Known for causing severe hepatotoxicity and Stevens-Johnson Syndrome (SJS). * **Indinavir:** Associated with nephrolithiasis (kidney stones).
Explanation: **Pseudomembranous colitis** is caused by the overgrowth of *Clostridioides difficile* (formerly *Clostridium*), typically following broad-spectrum antibiotic therapy. **1. Why Oral Vancomycin is the Correct Answer:** According to the latest clinical guidelines (IDSA/SHEA), **Oral Vancomycin** or **Fidaxomicin** are the first-line treatments for both mild and severe *C. difficile* infections. Vancomycin is a glycopeptide that inhibits bacterial cell wall synthesis. It is active against many gram-positive anaerobes including *C. difficile* [1]. It must be administered **orally** because it is poorly absorbed from the gut, allowing it to reach high, effective concentrations directly at the site of infection in the colon [1]. **2. Analysis of Incorrect Options:** * **Metronidazole (B):** Previously the first-line drug for mild cases, it is now considered a second-line alternative (only if Vancomycin/Fidaxomicin are unavailable) due to increasing resistance and inferior clinical outcomes. Oral metronidazole is an appropriate drug for mild to moderate cases of *C. difficile*-associated infection, and oral vancomycin is also a reasonable alternative [2]. * **Clindamycin (C):** This is actually a notorious **causative agent** of pseudomembranous colitis. It suppresses normal gut flora, allowing *C. difficile* to flourish. * **Penicillin G (D):** This is ineffective against *C. difficile* and has no role in treating anaerobic bowel infections of this nature. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Oral Vancomycin or Fidaxomicin. * **Route Matters:** IV Vancomycin is **ineffective** for colitis because it does not cross the intestinal barrier into the lumen. * **Fidaxomicin:** A macrocyclic antibiotic that is often preferred over Vancomycin due to lower recurrence rates (though more expensive). * **Life-threatening/Fulminant cases:** A combination of high-dose oral Vancomycin plus IV Metronidazole is used. * **Most common cause:** While Clindamycin has the highest *relative* risk, **Amoxicillin** and **Cephalosporins** are the most common causes due to their frequent use.
Explanation: In most cases, acute diarrhea is viral or self-limiting, and routine antibiotic use is discouraged as it can prolong the carrier state or lead to resistance. However, specific clinical scenarios necessitate antimicrobial therapy to prevent systemic complications and reduce morbidity. **Explanation of Options:** * **Dysentery (Option A):** The presence of blood and mucus in stools indicates invasive pathogens (e.g., *Shigella*, *Campylobacter*, or *E. histolytica*). Antibiotics are mandatory here to eradicate the pathogen and prevent complications like intestinal perforation or HUS. * **High-grade Fever (Option B):** Fever suggests systemic invasion or a high bacterial load (e.g., Enteric fever or Salmonellosis). Antibiotics help limit the systemic inflammatory response and prevent bacteremia. * **Immunocompromised State (Option C):** Patients with HIV/AIDS, malignancy, or those on immunosuppressants are at high risk for opportunistic infections and sepsis. Prophylactic or early therapeutic antibiotics are life-saving in these cohorts. Since all three conditions represent scenarios where the benefits of antibiotics outweigh the risks, **Option D (All of the above)** is the correct choice. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** For most bacterial diarrheas (including Shigella and Campylobacter), **Fluoroquinolones** (e.g., Ciprofloxacin) are the traditional DOC, though **Azithromycin** is now preferred in many regions due to rising resistance. * **Cholera:** Doxycycline is the DOC (single dose). * **Clostridioides difficile:** Oral Vancomycin or Fidaxomicin are the preferred treatments. * **Avoid Loperamide:** Never give anti-motility agents in dysentery, as they can worsen the condition by delaying the clearance of toxins.
Explanation: **Explanation:** The management of nerve involvement in leprosy is critical to prevent permanent disability. When a patient presents with a **nerve abscess** (most commonly involving the ulnar nerve), it represents a localized collection of caseous material within the nerve sheath. **1. Why Incision and Drainage (I&D) is correct:** A nerve abscess is a surgical emergency in the context of leprosy. The accumulation of pus increases **intraneural pressure**, which leads to rapid ischemia and irreversible destruction of nerve fibers. Medical management alone cannot evacuate the collection. Therefore, **longitudinal incision of the nerve sheath (epineurotomy) and drainage** of the abscess is the definitive treatment to decompress the nerve and preserve motor and sensory function. **2. Why other options are incorrect:** * **High dose steroids (Option A):** While steroids are the mainstay for treating *Type 1 reactions* (neuritis), they cannot drain a physical collection of pus. They are used post-operatively to reduce edema but are not the primary treatment for an abscess. [1] * **Thalidomide (Option C):** This is the drug of choice for *Type 2 reactions (Erythema Nodosum Leprosum)*. It has no role in treating a localized nerve abscess. * **High dose Clofazimine (Option D):** Clofazimine has anti-inflammatory properties used in chronic ENL, but it is ineffective for the acute mechanical compression caused by an abscess. [2] **Clinical Pearls for NEET-PG:** * **Most common nerve involved in Leprosy:** Ulnar nerve. * **Most common nerve involved in Nerve Abscess:** Ulnar nerve. * **Steroid of choice for Lepra reactions:** Prednisolone. * **Silent Neuritis:** Nerve damage occurring without overt symptoms of inflammation; also managed with steroids. * **Surgical indication:** If there is no improvement in nerve function after 4–6 weeks of optimal steroid therapy, surgical decompression is indicated.
Explanation: **Explanation:** **Correct Answer: B. Vancomycin** Redman syndrome (now more accurately termed **Vancomycin Infusion Reaction**) is a common infusion-related reaction associated with the rapid intravenous administration of Vancomycin. * **Mechanism:** It is a **pseudo-allergic reaction** (not a true IgE-mediated Type I hypersensitivity). Rapid infusion triggers the direct degranulation of mast cells and basophils, leading to the release of **histamine**. * **Clinical Presentation:** Patients develop pruritus, an erythematous rash (flushing) involving the face, neck, and upper torso, and occasionally hypotension. * **Prevention:** It can be prevented by slowing the infusion rate (administering over at least 60 minutes) or pre-treating with antihistamines. **Why other options are incorrect:** * **A. Rifampicin:** Known for causing harmless **orange-red discoloration** of body fluids (urine, sweat, tears). It can also cause a "Flu-like syndrome" if taken irregularly. * **C. Chloramphenicol:** Classically associated with **Gray Baby Syndrome** (due to deficient glucuronidation in neonates) and bone marrow suppression (aplastic anemia). * **D. Tetracycline:** Notable for causing **Fanconi syndrome** (if expired), tooth discoloration in children, and photosensitivity. **High-Yield Clinical Pearls for NEET-PG:** * **Vancomycin** is the drug of choice for **MRSA** (Methicillin-resistant *Staphylococcus aureus*). * Other side effects of Vancomycin include **Ototoxicity** and **Nephrotoxicity** (especially when combined with Aminoglycosides). * If a patient develops Redman syndrome, the immediate step is to **stop or slow the infusion** and administer diphenhydramine.
Explanation: **Explanation:** The correct answer is **Cefoperazone**. **1. Why Cefoperazone is Correct:** Cefoperazone is a **third-generation cephalosporin** specifically known for its extended spectrum against Gram-negative bacteria, including *Pseudomonas aeruginosa*. In the NEET-PG context, it is crucial to remember the "Antipseudomonal Cephalosporins." These include: * **3rd Generation:** Cefoperazone and Ceftazidime. * **4th Generation:** Cefepime and Cefpirome. * **5th Generation:** Ceftolozane (used in combination with Tazobactam). **2. Analysis of Incorrect Options:** * **Cefpodoxime (Option A):** An oral 3rd-generation cephalosporin. While it has good activity against many Gram-negative organisms, it lacks activity against *Pseudomonas*. * **Cefotetan (Option B):** A 2nd-generation cephalosporin (specifically a Cephamycin). It is notable for its **anti-anaerobic** activity and its side effect of causing disulfiram-like reactions, but it is not effective against *Pseudomonas*. * **Ceforanide (Option D):** A 2nd-generation cephalosporin with an intermediate half-life, primarily used for surgical prophylaxis; it lacks antipseudomonal coverage. **3. High-Yield Clinical Pearls for NEET-PG:** * **Biliary Excretion:** Cefoperazone is primarily excreted via **bile**, making it safe in patients with renal failure without dose adjustment. However, it can cause biliary sludge. * **Disulfiram-like Reaction:** Like Cefotetan, Cefoperazone contains a **methylthiotetrazole (MTT) side chain**, which can cause hypoprothrombinemia (bleeding) and disulfiram-like reactions with alcohol. * **Synergy:** Cefoperazone is frequently combined with **Sulbactam** to broaden its spectrum against beta-lactamase-producing organisms.
Explanation: **Explanation:** **1. Why Option A is the Correct (False) Statement:** Chloroquine is a **highly effective blood schizonticide**. It acts primarily on the **erythrocytic stage** of all malaria species (*P. falciparum, P. vivax, P. ovale, and P. malariae*). It has **no activity** against the exo-erythrocytic (liver) stages or latent tissue stages (hypnozoites). Therefore, it cannot prevent relapses in *P. vivax* or *P. ovale* infections. **2. Analysis of Other Options:** * **Option B (DNA/RNA):** While the primary mechanism of chloroquine is the inhibition of heme polymerase (preventing the conversion of toxic heme to non-toxic hemozoin), it also intercalates into the parasite’s DNA and inhibits RNA synthesis at higher concentrations. * **Option C (Pigmentation):** Long-term use of chloroquine (often for rheumatological conditions) can lead to bluish-grey or slate-grey pigmentation of the nails, hard palate, and skin due to drug-melanin complexes. * **Option D (Drug Accumulation):** Chloroquine is a weak base. It concentrates significantly (up to 100-fold) within the acidic food vacuoles of **infected erythrocytes** compared to uninfected ones, which is central to its selective toxicity. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** Mutation in the **PfCRT** (Plasmodium falciparum Chloroquine Resistance Transporter) gene, which pumps the drug out of the vacuole. * **Ocular Toxicity:** Causes "Bull’s Eye Maculopathy" (retinopathy) due to binding with melanin in the retina. * **Drug of Choice:** Still the DOC for sensitive malaria and malaria in **pregnancy**. * **Contraindication:** Avoid in patients with G6PD deficiency (risk of hemolysis) and Psoriasis (may exacerbate skin lesions).
Explanation: **Explanation:** Ethambutol is a bacteriostatic first-line antitubercular drug. The correct answer is **Visual disturbance** because the most significant dose-dependent adverse effect of Ethambutol is **Retrobulbar Neuritis**. 1. **Why Visual Disturbance?** Ethambutol can cause inflammation of the optic nerve, leading to decreased visual acuity, central scotoma, and **red-green color blindness**. It is generally avoided in children (typically those under 5–6 years old) because they are unable to reliably report early changes in vision or perform standard visual acuity and color perception tests (like Ishihara charts), making the toxicity difficult to monitor until irreversible damage occurs. 2. **Why other options are incorrect:** * **Dental maldevelopment:** This is a classic side effect of **Tetracyclines**, which chelate calcium and deposit in developing teeth and bones. * **Renal failure:** While Ethambutol is excreted renally (requiring dose adjustment in renal failure), it is not primarily nephrotoxic. Aminoglycosides (like Streptomycin) are more commonly associated with nephrotoxicity. * **Growth retardation:** This is associated with long-term **Corticosteroid** use or **Quinolones** (due to potential cartilage damage in animal studies), not Ethambutol. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits **Arabinosyl transferase**, thereby interfering with cell wall (arabinogalactan) synthesis. * **Monitoring:** Baseline and monthly visual acuity and color vision testing are mandatory for patients on Ethambutol. * **Hyperuricemia:** Ethambutol decreases the excretion of uric acid, which may precipitate **Acute Gout** (similar to Pyrazinamide). * **Safety:** It is considered the safest first-line anti-TB drug during **pregnancy**.
Explanation: **Explanation:** Metronidazole is a nitroimidazole derivative and is considered the drug of choice for invasive amoebiasis. Its mechanism of action involves the reduction of its nitro group by anaerobic organisms to form reactive intermediates that cause DNA strand breakage, leading to cell death. **Why Option A is Correct:** Metronidazole is a **systemic and luminal amoebicide** that acts specifically against the **trophozoite** (motile, feeding) stage of *Entamoeba histolytica*. It is highly effective against trophozoites residing in the intestinal wall (intestinal amoebiasis) and those that have migrated to other organs, most commonly the liver (extraintestinal amoebiasis/liver abscess). **Why Other Options are Incorrect:** * **Options B & C:** Metronidazole has **no activity against the cyst stage** of the parasite. Cysts are the dormant, infective forms with thick walls that are resistant to many drugs. To eradicate cysts and prevent a carrier state, "luminal amoebicides" like **Diloxanide furoate, Paromomycin, or Iodoquinol** must be used. * **Option D:** While true, it is incomplete. Metronidazole’s clinical utility lies in its ability to reach therapeutic concentrations in both the gut wall and systemic tissues (like the liver), making it effective for both sites. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Metronidazole is the DOC for hepatic amoebiasis, giardiasis, and trichomoniasis. * **The "Sequential" Rule:** In amoebic liver abscess, always follow Metronidazole treatment with a luminal amoebicide (e.g., Diloxanide furoate) to ensure the eradication of cysts in the gut lumen. * **Side Effects:** Look for "Metallic taste" and the **Disulfiram-like reaction** with alcohol in clinical vignettes. * **Safety:** It is generally avoided in the first trimester of pregnancy.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free